Jump to content
The World News Media

Once-Monthly MS Injection Approved in US - Wall Street Journal

Recommended Posts

  • Administrator
Wall Street Journal

Once-Monthly MS Injection Approved in US
Wall Street Journal
U.S. regulators approved the once-monthly, self-administered injection to treat multiple sclerosis made by Biogen Inc. BIIB 0.28 % and AbbVie Inc., ABBV 1.31 % but with a warning about the drug causing possible liver damage. Biogen and AbbVie are ...
Biogen and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA™ (daclizumab) for Multiple SclerosisPR Newswire (press release)
FDA Approves Daclizumab (Zinbryta ) for Multiple SclerosisMedscape
FDA approves Zinbryta to treat multiple sclerosisFDA.gov
Reuters -Seeking Alpha -The Ledger Gazette
all 13 news articles »


Link to comment
Share on other sites

  • Views 234
  • Replies 0
  • Created
  • Last Reply

Top Posters In This Topic

Popular Days

Top Posters In This Topic

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Create New...

Important Information

Terms of Service Confirmation Terms of Use Privacy Policy Guidelines We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.